Vaiomer and Physiogenex forge partnership to provide integrated services to nutrition and pharma companies.
Physiogenex, a leading contract research organization providing validated nutritional animal models to evaluate compounds targeting metabolic diseases, and Vaiomer, a pioneer in microbiome science focusing on the development of novel biomarkers, therapeutic targets and drugs for cardiometabolic diseases,announced they have entered into commercial partnership. Read more...
BioEurope, November 2-4, 2015 in Munich, Germany
Schedule a meeting with us if you are attending to the summit!
3rd World Congress on Targeting Microbiota, October 21-23, 2015
Vaiomer will be present at this congress. Come to see us in Paris and don't miss the talk!
Meet us at the Human Microbiome congress in Verona, Italy
We will be presenting our results on blood and tissue metagenomic analysis of patients with metabolic disease.Full program at www.somedverona2015.org
Meet us at the WCITT2D, London
We will present an E-poster on "16S metagenomics from adipose tissue of patients with metabolic disease".Take a look at the full conference program at www.wcitt2d.org.
Vaiomer will attend the Microbiome R&D and Business Collaboration Forum in London
Come and visit us at booth number 4.Click here to learn more about the event.
Vaiomer will attend the BIO-Europe Conference, Frankfurt, Germany
Information about BIO-Europe Conference.
To meet Vaiomer’s team or for more information on our technical expertise and services, please contact us.
Vaiomer will attend the 2nd World Congress on Targeting Microbiota at Institut Pasteur, Paris.
Information about 2nd World Congress on Targeting Microbiota.
To meet Vaiomer’s team or for more information on our technical expertise and services, please contact us.
The new Vaiomer website with additional content has been launched.